Streetbeat News

Marketing

NOVA

Sunnova Energy has announced the expansion of its Global Command Center, aiming to redefine customer service standards in the solar industry. This strategic move is expected to enhance the company's service capabilities and customer satisfaction.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 12:33 pm

SRDX

Surmodics announced that Dr. Peter A. Schneider will present 36-month data from its Transcend clinical trial at the 50th Annual Veith Symposium in New York. This presentation could provide insights into the long-term efficacy and safety of Surmodics' medical devices.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 12:31 pm

NGVC

Natural Grocers has announced the launch of its second annual 'Heroes in Aprons' holiday fundraiser. The initiative is designed to support the company's staff during the holiday season.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 12:30 pm

EXTR

Extreme Networks (EXTR) has announced that two NHL clubs will implement its Wi-Fi 6 and Wi-Fi 6E-ready solutions to enhance fan experiences, optimize arena operations, and obtain valuable data insights.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 12:29 pm

CMMB

Chemomab Therapeutics presented a poster at the American College of Rheumatology Convergence 2023, highlighting the significance of its CCL24 target in the development of systemic sclerosis. This could indicate progress in their research and potential for future treatment options.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 12:19 pm

GNS

Genius Group has announced the launch of the Exponential Entrepreneur Awards in collaboration with OpenExO. The awards aim to recognize and celebrate entrepreneurs who have made significant contributions to their industries through innovative and exponential growth strategies. This initiative could potentially enhance Genius Group's reputation and visibility in the entrepreneurial and educational sectors.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 12:12 pm

ABBV

AbbVie has published detailed results in The Lancet on the efficacy, safety, and tolerability of UBRELVY (ubrogepant) 100 mg for treating migraines when taken during the prodrome phase of an attack. The findings could influence the use of UBRELVY in early treatment stages of migraines.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 12:04 pm

NPO

EnPro Industries has announced that it will be changing its name to Enpro. The company, which is listed under the ticker symbol NPO, is preparing for a rebranding that will include a name change to reflect its evolving business and market position.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 11:32 am

TBPH

Theravance Biopharma announced it will present new data on Ampreloxetine at the 34th International Symposium on the Autonomic Nervous System. This event could provide insights into the drug's efficacy and potential market impact.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 11:11 am

CVNA

Carvana has expanded its same-day delivery service to customers in the Dallas-Fort Worth area, aiming to enhance the car buying experience by providing faster delivery options.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 11:03 am